Sandoz VP-Biopharma Development Ajaz Hussain: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
In the wake of Omnitrope’s approval in the U.S. and Europe, Sandoz is moving forward with a robust biosimilar pipeline.